Sarcopenic Obesity, the Possible Culprit for Nonalcoholic Fatty Liver Disease or Fibrosis

참고문헌 (10)

1. Lee YH, "Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance : Nationwide surveys(KNHANES 2008-2011)", J Hepatol, 63, pp.486~493 (2015)
2. Koo BK, "Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis", J Hepatol, 66, pp.123~131 (2017)
3. Cruz-Jentoft AJ, "Sarcopenia : European consensus on definition and diagnosis. Report of the European Working Group on Sarcopenia in Older People", Age Ageing, 39, pp.412~423 (2010)
4. Song Wolhwa, "Association between Sarcopenic Obesity Status and Nonalcoholic Fatty Liver Disease and Fibrosis", Gut and Liver, 17(1), pp.130~138 (2023), 거트앤리버 소화기연관학회협의회[DOI]
5. Park H, "Selecting the target population for screening of hepatic fibrosis in primary care centers in Korea", J Clin Med, 11, pp.1474~ (2022)
6. Jensen B, "Limitations of fat-free mass for the assessment of muscle mass in obesity", Obes Facts, 12, pp.307~315 (2019)
7. Peng TC, "Nonalcoholic fatty liver disease and sarcopenia in a Western population(NHANES III) : the importance of sarcopenia definition", Clin Nutr, 38, pp.422~428 (2019)
8. Kashiwagi K, "A significant association of non-obese non-alcoholic fatty liver disease with sarcopenic obesity", Clin Nutr ESPEN, 38, pp.86~93 (2020)
9. Bhanji RA, "Sarcopenia in hiding : the risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis", Hepatology, 66, pp.2055~2065 (2017)
10. Sinn DH, "Nonalcoholic fatty liver disease and accelerated loss of skeletal muscle mass : a longitudinal cohort study", Hepatology, 76, pp.1746~1754 (2022)

관련 논문AI추천